Form 4: LifeStance Health Director Robert Bessler Reports Future RSU Grant and Beneficial Ownership

LifeStance Health Group, Inc. Director Robert Bessler filed a Form 4 detailing the acquisition of 35,714 restricted stock units scheduled for June 11, 2025, alongside his current direct and indirect beneficial ownership.

Summary

• Robert Bessler, a Director of LifeStance Health Group, Inc. (LFST), reported the acquisition of 35,714 shares of common stock through restricted stock units (RSUs).
• The transaction date for this acquisition is listed as June 11, 2025, with a reported price of $0 per share, indicating a non-cash grant.
• Following this reported transaction, Mr. Bessler's direct beneficial ownership will be 57,619 shares of common stock.
• His indirect beneficial ownership includes 1,421,990 shares held by Vitthal LLC, 1,538,790 shares held by Shama LLC, and 36,363 shares held by Alpine Glow Capital, where Mr. Bessler is the manager and sole member.
• The reporting person disclaims beneficial ownership of the shares held by Vitthal LLC, Shama LLC, and Alpine Glow Capital, except to the extent of his pecuniary interest therein.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive due to a director's acquisition of shares, which generally signals confidence and aligns interests. The unusual future transaction date is a minor point of note but does not significantly detract from the overall sentiment of insider alignment.

Positives

• The acquisition of restricted stock units by a director aligns management's interests with those of shareholders, as the value of these units is tied to the company's stock performance.

Negatives

• The transaction date of June 11, 2025, is in the future, which is unusual for a Form 4 filing that typically reports completed transactions. This could indicate a pre-planned grant or an administrative anomaly.

Risks

• The future transaction date (June 11, 2025) for the RSU grant is atypical for a Form 4, which usually reports past events, potentially leading to questions regarding the nature or timing of the disclosure.
• The reporting person disclaims beneficial ownership for a significant portion of the indirectly held shares (Vitthal LLC, Shama LLC, Alpine Glow Capital), limiting the direct accountability for these holdings under Section 16 of the Exchange Act.

Industry Context

This filing is a standard insider transaction report and does not provide broader industry context or trends for the mental health services sector in which LifeStance Health operates.

Related Party Transactions

• Robert Bessler's indirect beneficial ownership includes shares held by Vitthal LLC, Shama LLC, and Alpine Glow Capital, entities with which he has a relationship (manager and sole member for Alpine Glow Capital), though he disclaims beneficial ownership except for his pecuniary interest.

Stakeholder Impact

• Shareholders may view the director's acquisition of shares, even through RSUs, as a positive signal of management's commitment and belief in the company's future prospects.
• The filing provides transparency regarding insider holdings and compensation structures, which is beneficial for investors assessing corporate governance.

Key Dates

Keywords

LifeStance Health Group, LFST, Robert Bessler, SEC Form 4, Insider Trading, Restricted Stock Units, RSU, Beneficial Ownership, Director Compensation, Corporate Governance